Molecular Biology Co-Op

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Are you ready to help build the next generation of molecular biology tools and platforms? At FL87, we push the boundaries of DNA design, precise cloning, and cell-based engineering to accelerate the discovery and development of transformative therapeutics and diagnostics.

As a member of our molecular biology team, you’ll work at the forefront of hands-on research from constructing DNA plasmids and optimizing cloning strategies to developing scalable workflows.

We’re Looking For:

• Highly motivated and enthusiastic co-op students eager to dive into fast-paced, impactful bench science
• Curious problem solvers who learn new techniques quickly and think creatively
• Individuals with a strong foundation in molecular biology and cell culture; experience with synthetic biology, genome engineering, or assay development is a plus.

What You’ll Do:

• Design, build, and QC DNA constructs using restriction cloning, Gibson/Golden Gate assembly, and PCR.
• Run agarose DNA gels to analyze PCR products and digests; perform gel extraction and DNA purification.
• Set up restriction enzyme digests and ligations; optimize reaction conditions and troubleshoot cloning workflows
• Perform core molecular and cell biology tasks, including DNA/RNA extraction, qPCR/RT-qPCR, transfection/transduction, and clonal line generation
• Analyze and clearly communicate experimental results; iterate protocols in collaboration with experienced scientists

Why Join Us:

• Contribute directly to impactful, platform-scale molecular biology
• Collaborate with a tight-knit, multidisciplinary team that values mentorship and scientific rigor
• Build a diverse toolkit spanning cloning, gel-based analysis, cell engineering, assay development, and data analysis

Qualifications:

• Pursuing a BS or MS in Molecular Biology, Cell Biology, Bioengineering, Biochemistry, or a related field
• Hands-on experience with core techniques: miniprep/midiprep, PCR, agarose gel electrophoresis, restriction enzyme digests, ligation, and DNA purification
• Strong organizational skills, attention to detail, and clear written/verbal communication

Embark on an exhilarating journey with FL87, where your contributions at the bench will accelerate breakthrough molecular biology and shape what’s possible in biotech. To apply, please send your resume and a brief note on your relevant coursework and lab experience.

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

 

The salary range for this role is $20 - $40. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. FL87 currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on FL87’s good faith estimate as of the date of publication and may be modified in the future.